recent bioavailability studies (continued)

2
from our files RECENT BIOAVAILABILITY STUDIES (continued) ... Cephradine Sex differences in the intramuscular absorption and bioavailability of cephradine. Vukovich, R.A. et al. Clinical Pharmacology and Therapeutics 18: 215 (1975) Effect of 2% procaine hydrochloride solution on the bioavailability of cephradine after intramuscular administration. Vukovich, R.A. et al. Current Therapeutic Research 18: 711 (1975) ... Digoxin Bioavailability of different lots of digoxin tablets from the same manufacturer. Lindenbaum, J. Clinical Pharmacology and Therapeutics 17: 296 (1975) Intersubject variation in absorption of digoxin in normal volunteers. Huffman, D.H. et al. Journal of Pharmaceutical Sciences 64: 433 (1975) Effect of particle size on the bioavailability of digoxin. Jounela, A.J. et a!. European Journal of Clinical Pharmacology 8: 365 (1975) Bioavailability studies with digoxin. Beveridge, T. et al. European Journal of Clinical Pharmacology 8: 37l (1975) Comparison of digoxin bioavailability from tablets and elixir during maintenance therapy. Ochs, H. et al. Klinische Wochenschrift 53: 425 (1975) Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction. Sharpe, D.N. et a!. British Heart Journal 37: 530 (1975) Problems associated with development of radioimmunoassay for urinary digoxin and its use in clinical assessment of biological availability. Hayward, R.P. et al. British Heart Journal 37: 560 (1975) Bioavailability of digoxin tablets in relation to their dissolution in vitro. Ylitalo, P. et al. Journal of Pharmaceutical Sciences 64: 1264 (1975) Bioavailabili.ty of digoxin tablets in Israel. Levy, M. et al. Harefuah 89: 153 (1975) Digoxin bioavailability: paradoxical increased toxicity on dosage reduction. Leach, R.H. British Medica1Journal3: 437 (1975) Methodological differences in correlating digoxin dissolution with bioavailability. Poust, R.I. et al. Journal of Pharmaceutical Sciences 64: 1583 (1975) Investigations on biological availability of beta-methyldigoxin from intensain 150-Lanitop and digoxin from intensain 150-Lanicor. Loskot, F. eta!. Herz/Kreislauf 7: 581 (1975) Biological availability of digoxin in patients with or without gastric resection. Ochs, H. et al. Deutsche Medizinische Wochenschrift 100: 2430 (1975) Superior bioavailability of digoxin solution in capsules. Mallis, G.l. et al. Clinical Pharmacology and Therapeutics 18: 761 (1975) Bioavailability of Jl-acetyldigoxin and digoxin (in German). Flasch, H. Klinische Wochenschrift 53: 873 (1975) Digoxin - Bioavailability Monograph. Journal of the American Pharmaceutical Association NS15: 43 (1975) Digoxin tablets - a review of the bioavailability problems. Sim, S.K. American Journal of Hospital Pharmacy 33: 44 (1976) Decreased bioavailability of digoxin produced by antacids and kaopectate. Brown, D.D. et al. American Journal of Cardiology 37: 123 (1976) Bioavailability of drugs: the digoxin dilemma. Greenblatt, D.J. eta!. Oinical PharmacokinetiCs 1: 36 (1976) Dissolution properties of digoxin tablets marketed in the Republic of Ireland. Corrigan, 0.1. et al. Irish Medical Journal 69: 60 (197 6) Comparative bioavailability of four dosage forms of digoxin in dogs. Krasula, R.W. et al. Federation Proceedings 35: 327 (1976) Bioavailability and pharmacokinetics of Jl-methyldigoxin after multiple oral and intravenous doses. Rietbrock, N. European Journal of Clinical Pharmacology 9: 373 (1976) Comparative pharmacokinetics of Jl-methyl digoxin and digoxin administered as tablets or encapsulated solution. Proceedings B.P.S. Dec 1975. Johnson, B.F. et al. British Journal of , Clinical Pharmacology 3: 349 (197 6) . A completely absorbed oral preparation of digoxin. Johnson, B.F. et al. Clinical Pharmacology and Therapeutics 19: 746 (1976) Assessment of the bioavailability of digoxin from t1xed combinations during multiple dosing. Gilfrich, H.J. et al. Innere Mediiin 3: 189 (1976) Equivalence of 'Lanoxin' tablets. Dobbs, Sylvia, M. et al. British Journal of Clinical Pharmacology 3: 514 (1976) ... Griseofulvin Bioavailability of micronized griseofulvin from corn oil-in-water emulsion aqueous suspension, and commercial tablet dosage forms in humans. Bates, T.R. et al. Journal of Pharmaceutical Sciences 64: 793 (1975) The bioavailability of griseofulvin PEG ultramicrosize (GRI5-PEG R) tablets in man under steady-state conditions. Barrett, W.E. et al. Current Therapeutic Research 18: 491 (1975) Comparative bioavailability of anhydrous griseofulvin and its chloroform solvate in man. Bates, Theodore, R. et al. Research Communications in Chemical Pathology and Pharma- cology 11: 233 (1975) The bioavailability of ultramicrosize griseofulvin tablets in man. Barrett, W.E. et al. Current Therapeutic Research 18: 501 (1975) ... Hydrochlorothiazide Bioavailability of hydrallazine and hydrochlorothiazide from separate and combination commercially available tablets. Wagner, W.E. et al. Clinical Pharmacology and Therapeutics 17: 247 (1975) Hydrochlorothiazide bioavailability: an evaluation of thirteen products. Meyer, M.C. et al. Current Therapeutics Research 17: 570 (1975) Bioavailability monograph -hydrochlorothiazide. Valentine Michelle, E. et al. American Journal of the Pharmaceutical Association 16: 47 (1976) ... Indomethacin Pharmacokinetics of indomethacin. Alvan, G. et al. Clinical Pharmacology and Therapeutics 18: 364 (1975) Ups and downs of indomethacin bioavailability. Brooks, P.M. et al. Annals of the Rheumatic Diseases 34: 465 (1975) ... Nitrofurantoin Inequivalency of nitrofurantoin products. Meyer, M.C. et al. Journal of the American Medical Association 232: 1009 (197 5) Qinical bioavailability of nitrofurantoin; a case of bioinequivalence. DiSanto, A.R. et al. International Journal of Clinical Pharma- cology and Biopharmacy 13: 220 (1976) The influence of food on nitrofurantoin bioavailability. Rosenberg, H.A. et al. Clinical Pharmacology and Therapeutics 20: 227 (1976) . .. Papaverine Pharmacokinetics and bioavailability of papaverine. Juhran, W. eta!. Arzneirnittel-Forschung 5: 773 (1975) INPHARMA 4th September, 1976 p19

Upload: ngokiet

Post on 20-Mar-2017

218 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: RECENT BIOAVAILABILITY STUDIES (continued)

from our files

RECENT BIOAVAILABILITY STUDIES (continued)

... Cephradine Sex differences in the intramuscular absorption and bioavailability

of cephradine. Vukovich, R.A. et al. Clinical Pharmacology and Therapeutics 18: 215 (1975)

Effect of 2% procaine hydrochloride solution on the bioavailability of cephradine after intramuscular administration. Vukovich, R.A. et al. Current Therapeutic Research 18: 711 (1975)

... Digoxin Bioavailability of different lots of digoxin tablets from the same

manufacturer. Lindenbaum, J. Clinical Pharmacology and Therapeutics 17: 296 (1975)

Intersubject variation in absorption of digoxin in normal volunteers. Huffman, D.H. et al. Journal of Pharmaceutical Sciences 64: 433 (1975)

Effect of particle size on the bioavailability of digoxin. Jounela, A.J. et a!. European Journal of Clinical Pharmacology 8: 365 (1975)

Bioavailability studies with digoxin. Beveridge, T. et al. European Journal of Clinical Pharmacology 8: 37l (1975)

Comparison of digoxin bioavailability from tablets and elixir during maintenance therapy. Ochs, H. et al. Klinische Wochenschrift 53: 425 (1975)

Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction. Sharpe, D.N. et a!. British Heart Journal 37: 530 (1975)

Problems associated with development of radioimmunoassay for urinary digoxin and its use in clinical assessment of biological availability. Hayward, R.P. et al. British Heart Journal 37: 560 (1975)

Bioavailability of digoxin tablets in relation to their dissolution in vitro. Ylitalo, P. et al. Journal of Pharmaceutical Sciences 64: 1264 (1975)

Bioavailabili.ty of digoxin tablets in Israel. Levy, M. et al. Harefuah 89: 153 (1975)

Digoxin bioavailability: paradoxical increased toxicity on dosage reduction. Leach, R.H. British Medica1Journal3: 437 (1975)

Methodological differences in correlating digoxin dissolution with bioavailability. Poust, R.I. et al. Journal of Pharmaceutical Sciences 64: 1583 (1975)

Investigations on biological availability of beta-methyldigoxin from intensain 150-Lanitop and digoxin from intensain 150-Lanicor. Loskot, F. eta!. Herz/Kreislauf 7: 581 (1975)

Biological availability of digoxin in patients with or without gastric resection. Ochs, H. et al. Deutsche Medizinische Wochenschrift 100: 2430 (1975)

Superior bioavailability of digoxin solution in capsules. Mallis, G.l. et al. Clinical Pharmacology and Therapeutics 18: 761 (1975)

Bioavailability of Jl-acetyldigoxin and digoxin (in German). Flasch, H. Klinische Wochenschrift 53: 873 (1975)

Digoxin - Bioavailability Monograph. Journal of the American Pharmaceutical Association NS15: 43 (1975)

Digoxin tablets - a review of the bioavailability problems. Sim, S.K. American Journal of Hospital Pharmacy 33: 44 (1976)

Decreased bioavailability of digoxin produced by antacids and kaopectate. Brown, D.D. et al. American Journal of Cardiology 37: 123 (1976)

Bioavailability of drugs: the digoxin dilemma. Greenblatt, D.J. eta!. Oinical PharmacokinetiCs 1: 36 (1976)

Dissolution properties of digoxin tablets marketed in the Republic of Ireland. Corrigan, 0.1. et al. Irish Medical Journal 69: 60 (197 6)

Comparative bioavailability of four dosage forms of digoxin in dogs. Krasula, R.W. et al. Federation Proceedings 35: 327 (1976)

Bioavailability and pharmacokinetics of Jl-methyldigoxin after multiple oral and intravenous doses. Rietbrock, N. European Journal of Clinical Pharmacology 9: 373 (1976)

Comparative pharmacokinetics of Jl-methyl digoxin and digoxin administered as tablets or encapsulated solution. Proceedings B.P.S. Dec 1975. Johnson, B.F. et al. British Journal of

, Clinical Pharmacology 3: 349 (197 6) . A completely absorbed oral preparation of digoxin. Johnson, B.F.

et al. Clinical Pharmacology and Therapeutics 19: 746 (1976) Assessment of the bioavailability of digoxin from t1xed combinations

during multiple dosing. Gilfrich, H.J. et al. Innere Mediiin 3: 189 (1976)

Equivalence of 'Lanoxin' tablets. Dobbs, Sylvia, M. et al. British Journal of Clinical Pharmacology 3: 514 (1976)

... Griseofulvin Bioavailability of micronized griseofulvin from corn oil-in-water

emulsion aqueous suspension, and commercial tablet dosage forms in humans. Bates, T.R. et al. Journal of Pharmaceutical Sciences 64: 793 (1975)

The bioavailability of griseofulvin PEG ultramicrosize (GRI5-PEG R) tablets in man under steady-state conditions. Barrett, W.E. et al. Current Therapeutic Research 18: 491 (1975)

Comparative bioavailability of anhydrous griseofulvin and its chloroform solvate in man. Bates, Theodore, R. et al. Research Communications in Chemical Pathology and Pharma­cology 11: 233 (1975)

The bioavailability of ultramicrosize griseofulvin tablets in man. Barrett, W.E. et al. Current Therapeutic Research 18: 501 (1975)

... Hydrochlorothiazide Bioavailability of hydrallazine and hydrochlorothiazide from

separate and combination commercially available tablets. Wagner, W.E. et al. Clinical Pharmacology and Therapeutics 17: 247 (1975)

Hydrochlorothiazide bioavailability: an evaluation of thirteen products. Meyer, M.C. et al. Current Therapeutics Research 17: 570 (1975)

Bioavailability monograph -hydrochlorothiazide. Valentine Michelle, E. et al. American Journal of the Pharmaceutical Association 16: 47 (1976)

... Indomethacin Pharmacokinetics of indomethacin. Alvan, G. et al. Clinical

Pharmacology and Therapeutics 18: 364 (1975) Ups and downs of indomethacin bioavailability. Brooks, P.M. et

al. Annals of the Rheumatic Diseases 34: 465 (1975)

... Nitrofurantoin Inequivalency of nitrofurantoin products. Meyer, M.C. et al. Journal

of the American Medical Association 232: 1009 (197 5) Qinical bioavailability of nitrofurantoin; a case of bioinequivalence.

DiSanto, A.R. et al. International Journal of Clinical Pharma­cology and Biopharmacy 13: 220 (1976)

The influence of food on nitrofurantoin bioavailability. Rosenberg, H.A. et al. Clinical Pharmacology and Therapeutics 20: 227 (1976)

. .. Papaverine Pharmacokinetics and bioavailability of papaverine. Juhran, W. eta!.

Arzneirnittel-Forschung 5: 773 (1975)

INPHARMA 4th September, 1976 p19

Page 2: RECENT BIOAVAILABILITY STUDIES (continued)

Comparison of papaverine values two hours and eight hours after absorption of two different salts of this alkaloid: papaverine hydrochloride and papaverine adenosine-monophosphate. Lifargue, P. et al. Gazette .Medicale de France 82: 2751 (1975)

... Penicillins Serum levels of penicillin V after oral administration of pediatric

preparations to healthy subjects. Rollag, H. Jr. et al. Acta Paediatrica Scandinavica 64: 421 (1975)

Bioavailability of different brands of phenoxymethylpenicillin. Simon, C. et al. Medizinische Klinik 70: 1637 (1975)

Bioavailability of various preparations and doses of penicillin V. Dimmling, Th. et al. European Journal of Clinical Pharrna­cology 10: 55 (1976)

Relative bioavailability of phenoxymethylpenicillin preparations in a cross-over study. Bergan, T. et a!. Acta Pharmacologica et Toxicologica 38: 308 (1976)

... Phenytoin Phenytoin dosage. Stewart, M.J. Lancet 2: 278 (1975) Dioavailabillty and single-dose pharrnacol"..in~tics of intn!musc.u!ar

phenytoin. Kostenbauder, H. B. eta!. Clinical Pharmacology and Therapeutics 18: 449 (1975)

Plasma phenytoin levels produced by various phenytoin preparations. Sansom, LN. et al. Medical Journal of Australia 2: 593 (1975)

Bioavailability of phenytoin from various pharmaceutical prepar­ations in children. Manson, J.I. et al. Medical Journal of Australia 2: 590 (1975)

Bioavailability monograph- phenytoin. Journal of the American Pharmaceutical Association 15: 647 (1975)

Bioavailability of phenytoin. A comparison of two preparations. Stewart, M.J. et al. European Journal of Clinical Pharmacology 9: 209 (1975)

Bioavailability of four brands of phenytoin tablets. Pentikainen, P.J. et al. European Journal of Oinical Pharmacology 9: 213 (1975)

Biological availability - a comparison of three phenytoin prepar­ations. Alvan, G. et al. Laekartidningen 72: 2623 (1975)

Bioavailability of phenytoin. Tammisto, P. et al. Lancet 1: 254 (1976)

Phenytoin: pharmacokinetics and bioavailability. Gugier, R. et a!. Clinical Pharmacology and Therapeutics 19: 135 (1976)

: . . Propoxyphene Propoxyphene bioavailability: An evaluation of ten products.

Slywka, G.W.A. et al. Journal of Oinical Pharmacology 15: 598 (1975)

Bioavailability monograph - Propoxyphene. Spaulding, G. et al. Journal of the American Pharmaceutical Association 16: 97 (1976)

Propoxyphene and norpropoxyphene: Influence of diet and fluid on plasma levels. Welling, P.G. et al. Oinical Pharmacology and Therapeutics 19: 559 (1976)

... Spironolactone A comparison of the dissolution and bioavailability characteristics

of three spironolactone tablet formulations, including pre­liminary data on two spironolactone metabolites. Tidd-, M.J. et a!. Journal of International Medical Research 4: 86 (1976)

Spironolactone. II. Bioavailability. Karim, A. et al. Oinical Pharmacology and Therapeutics 19: 170 (1976)

... Tetracyclines Bioavailability and dissolution of different formulations of

oxytetracycline preparations. Hart, A. et al. British Journal of Oinical Pharmacology 2: 277 (197 5)

Bioavailability in commercial oxytetracycline and tetracycline products. Wood, J.H. eta!. Journal of Clinical Pharmacology 15: 568 (1975)

Bioavailability monograph- Oxytetracycline. Journal of the American Pharmaceutical Association 15: 461 (197 5)

Effect of crystal forms on the dissolution behaviour and bio­availability of tetracycline, chlortetracycline, and oxytetracycline bases. Miyazaki, S. et al. Chemical and Pharmaceutical Bulletin 23: 552 (1975)

The bioavailability and dissolution behaviour of n·ine brands of tetracycline tablets. Lovering, E.G. eta!. Canadian Journal of

Pharmaceutical Sciences 10: 36 (1975) The influence of mucin on the bioavailability of tetracycline.

Kellaway, I.W. et al. Journal of Pharmacy and Pharmacology 27: 281 (1975)

The effect of mucin on the bioavailability of tetracycline from the gastrointestinal tract; in vivo, in vitro correlations. Braybrooks, M.P. et al. Journal of Pharmacy and Pharmacology 27: 508 (1975)

Bioavailability monograph - Tetracycline. Journal of the American Pharmaceutical Association 15: 709 (1975)

... Theo phyl!i ne Influence of diet and fluid on bioavailability of theophylline. Welling

P.G. et al. Clinical Pharmacology and Therapeutics 17: 475 (1975) A rapidly dissolving theophylline tablet. Cohen, A. eta!. Current

Therapeutic Research 17: 497 (1975) Influence of formulation on bioavailability of theophylline. Welling,

P.G. et al. Journal of Oinical Pharmacology 16: 43 (1976)